Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors Pharmaceutical Investing
ACADIA Pharmaceuticals Announces Positive Top-line Results from Phase 2 CLARITY Trial Life Science Investing
Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement Life Science Investing
PreveCeutical Provides Update on Visit to Penta 5 Group’s Facility for Due Diligence on Proposed Acquisition Pharmaceutical Investing
Acerus Announces Expansion of NATESTO® Agreement with medac and the Submission of NATESTO® Dossier in Europe Pharmaceutical Investing
